Suraksha Diagnostic IPO: Subscribed 25% on Day 2; Check GMP Updates

Suraksha Diagnostic IPO Live Updates (03 Dec 2024)

Key Risk Factors

  1. Shortage of Skilled Labor:
    • Significant lack of full-time doctors and staff in the diagnostics industry.
    • Training and retaining experienced employees is critical for sustainability.
  2. High Cost of Equipment:
    • Constant technology upgrades require significant capital investments.
    • Maintenance costs and the need for skilled technicians further increase expenses.
  3. Intense Competition:
    • The diagnostics industry is highly fragmented with low entry barriers.
    • Standalone players dominate the market, increasing competition.

Grey Market Premium (GMP)

  • Current GMP: ₹0, reflecting weak investor interest.
  • Listing Expectations: Flat to discount listing predicted if trends continue.

IPO Structure

  • Offer for Sale (OFS): Entire IPO involves an OFS of 1.91 crore shares.
  • Proceeds: The company will not receive funds; proceeds go to selling shareholders.

Company Overview

  • Headquarters: Largest integrated diagnostic chain in East India (FY23 operating income).
  • Services: Pathology, radiology testing, and medical consultation.
  • Network:
    • 1 flagship central reference lab.
    • 8 satellite labs.
    • 194 customer touchpoints, including 48 diagnostic centres and 146 sample collection centres.
  • Presence: Operates in West Bengal, Bihar, Assam, and Meghalaya (as of March 31, 2024).

Financial Performance

  • Revenue: FY22: ₹225 crore | FY23: ₹193 crore | FY24: ₹222 crore.
  • Earnings Metrics:
    • Average EPS: ₹3.27.
    • Return on Net Worth (RoNW): 11.05%.

Valuation

  • Price-to-Earnings (P/E):
    • FY25 (annualized earnings): 74.87.
    • FY24: 99.32.
  • Conclusion: IPO appears fully priced.

Expert Opinions

  1. Swastika Investmart:
    • Valuation is aggressive.
    • Recommend avoiding the IPO.
  2. Anand Rathi:
    • Limited market presence (focused on East India).
    • Issue is overpriced; avoid recommendation.

Key Dates

  • Allotment Finalization: December 4, 2024.
  • Listing Date: December 6, 2024.

Subscription Details

  • Overall Subscription: 25% by Day 2.
    • Retail Investors: Subscribed 45%.
    • Non-Institutional Investors (NIIs): Subscribed 13%.

Price Band & Lot Size

Join The Discussion

Compare listings

Compare